date/time interval
- September 1, 2019 - August 31, 2023
Developing and enhancing novel cancer immunotherapies by harnessing the anti-cancer abilities of patients' own Natural Killer immune cells
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 200000